New peptide drug hopes to boost brain repair after stroke
NCT ID NCT07581210
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental drug called QD202 in people who have had an acute ischemic stroke and received clot-busting medication. The drug is designed to cross into the brain and protect nerve cells. About 120 participants will receive either QD202 or a placebo daily for 5 days, and researchers will monitor safety and recovery over 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QD202 (a peptide designed to cross the blood-brain barrier and protect brain cells)
- What this could lead to
- If successful, this could point toward a new treatment to improve recovery and reduce disability after a stroke.
- What could go wrong
- This is an early Phase 2 trial with only 120 participants, so results may not apply to all stroke patients. The drug may not prove more effective than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benxi Central Hospital
RECRUITINGBenxi, Liaoning, China
-
Central Hospital Affiliated to Shenyang Medical College
RECRUITINGShengyang, Liaoning, China
-
General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group
RECRUITINGFuxin, Liaoning, China
-
General Hospital of Northern Theater Command
RECRUITINGShenyang, Liaoning, China
-
Huashan Hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, China
-
Jilin Province People's Hospital
RECRUITINGChangchun, Jilin, China
-
Linfen Central Hospital
RECRUITINGLinfen, Shanxi, China
-
Linyi People's Hospital
RECRUITINGLinyi, Shandong, China
-
Luoyang Central Hospital
RECRUITINGLuoyang, Henan, China
-
Meihe Hospital the First Hospital of Jilin University
RECRUITINGMeihekou, Jilin, China
-
Meizhou People's Hospital
RECRUITINGMeizhou, Guangdong, China
-
Nanshi Hospital of Nanyang
RECRUITINGNanyang, Henan, China
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, China
-
Weifang People's Hospital
RECRUITINGWeifang, Shandong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?